The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Minimal Residual Disease (MRD) Testing Market 2024 by Company, Regions, Type and Application, Forecast to 2029

Global Minimal Residual Disease (MRD) Testing Market 2024 by Company, Regions, Type and Application, Forecast to 2029

Publishing Date : Aug, 2023

License Type :
 

Report Code : 1770140

No of Pages : 102

Ask Your Query

Synopsis
The global Minimal Residual Disease (MRD) Testing market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period.

The Global Info Research report includes an overview of the development of the Minimal Residual Disease (MRD) Testing industry chain, the market status of Specialty Clinics (Flow Cytometry, Polymerase Chain Reaction), Hospitals (Flow Cytometry, Polymerase Chain Reaction), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Minimal Residual Disease (MRD) Testing.

Regionally, the report analyzes the Minimal Residual Disease (MRD) Testing markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Minimal Residual Disease (MRD) Testing market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:

The report presents comprehensive understanding of the Minimal Residual Disease (MRD) Testing market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Minimal Residual Disease (MRD) Testing industry.

The report involves analyzing the market at a macro level:

Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Flow Cytometry, Polymerase Chain Reaction).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Minimal Residual Disease (MRD) Testing market.

Regional Analysis: The report involves examining the Minimal Residual Disease (MRD) Testing market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Minimal Residual Disease (MRD) Testing market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Minimal Residual Disease (MRD) Testing:

Company Analysis: Report covers individual Minimal Residual Disease (MRD) Testing players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Minimal Residual Disease (MRD) Testing This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Specialty Clinics, Hospitals).

Technology Analysis: Report covers specific technologies relevant to Minimal Residual Disease (MRD) Testing. It assesses the current state, advancements, and potential future developments in Minimal Residual Disease (MRD) Testing areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Minimal Residual Disease (MRD) Testing market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation

Minimal Residual Disease (MRD) Testing market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Market segment by Type

  • Flow Cytometry
  • Polymerase Chain Reaction
  • Next-generation Sequencing
  • Liquid Biopsies

Market segment by Application

  • Specialty Clinics
  • Hospitals
  • Research Institutions

Market segment by players, this report covers

  • Sysmex Corporation
  • Natera
  • Asuragen
  • Quest Diagnostics
  • Mission Bio
  • LabCorp
  • Guardant Health
  • NeoGenomics Laboratories
  • ARUP Laboratories
  • NeoGenomics , Inc
  • Opko Health
  • Bio-Rad Laboratories

Market segment by regions, regional analysis covers

  • North America (United States, Canada, and Mexico)
  • Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
  • South America (Brazil, Argentina and Rest of South America)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:

Chapter 1, to describe Minimal Residual Disease (MRD) Testing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Minimal Residual Disease (MRD) Testing, with revenue, gross margin and global market share of Minimal Residual Disease (MRD) Testing from 2018 to 2023.
Chapter 3, the Minimal Residual Disease (MRD) Testing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Minimal Residual Disease (MRD) Testing market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Minimal Residual Disease (MRD) Testing.
Chapter 13, to describe Minimal Residual Disease (MRD) Testing research findings and conclusion.

Index

1 Market Overview
1.1 Product Overview and Scope of Minimal Residual Disease (MRD) Testing
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Minimal Residual Disease (MRD) Testing by Type
1.3.1 Overview: Global Minimal Residual Disease (MRD) Testing Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Minimal Residual Disease (MRD) Testing Consumption Value Market Share by Type in 2022
1.3.3 Flow Cytometry
1.3.4 Polymerase Chain Reaction
1.3.5 Next-generation Sequencing
1.3.6 Liquid Biopsies
1.4 Global Minimal Residual Disease (MRD) Testing Market by Application
1.4.1 Overview: Global Minimal Residual Disease (MRD) Testing Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Specialty Clinics
1.4.3 Hospitals
1.4.4 Research Institutions
1.5 Global Minimal Residual Disease (MRD) Testing Market Size & Forecast
1.6 Global Minimal Residual Disease (MRD) Testing Market Size and Forecast by Region
1.6.1 Global Minimal Residual Disease (MRD) Testing Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Minimal Residual Disease (MRD) Testing Market Size by Region, (2018-2029)
1.6.3 North America Minimal Residual Disease (MRD) Testing Market Size and Prospect (2018-2029)
1.6.4 Europe Minimal Residual Disease (MRD) Testing Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Minimal Residual Disease (MRD) Testing Market Size and Prospect (2018-2029)
1.6.6 South America Minimal Residual Disease (MRD) Testing Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Minimal Residual Disease (MRD) Testing Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 Sysmex Corporation
2.1.1 Sysmex Corporation Details
2.1.2 Sysmex Corporation Major Business
2.1.3 Sysmex Corporation Minimal Residual Disease (MRD) Testing Product and Solutions
2.1.4 Sysmex Corporation Minimal Residual Disease (MRD) Testing Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Sysmex Corporation Recent Developments and Future Plans
2.2 Natera
2.2.1 Natera Details
2.2.2 Natera Major Business
2.2.3 Natera Minimal Residual Disease (MRD) Testing Product and Solutions
2.2.4 Natera Minimal Residual Disease (MRD) Testing Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Natera Recent Developments and Future Plans
2.3 Asuragen
2.3.1 Asuragen Details
2.3.2 Asuragen Major Business
2.3.3 Asuragen Minimal Residual Disease (MRD) Testing Product and Solutions
2.3.4 Asuragen Minimal Residual Disease (MRD) Testing Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Asuragen Recent Developments and Future Plans
2.4 Quest Diagnostics
2.4.1 Quest Diagnostics Details
2.4.2 Quest Diagnostics Major Business
2.4.3 Quest Diagnostics Minimal Residual Disease (MRD) Testing Product and Solutions
2.4.4 Quest Diagnostics Minimal Residual Disease (MRD) Testing Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Quest Diagnostics Recent Developments and Future Plans
2.5 Mission Bio
2.5.1 Mission Bio Details
2.5.2 Mission Bio Major Business
2.5.3 Mission Bio Minimal Residual Disease (MRD) Testing Product and Solutions
2.5.4 Mission Bio Minimal Residual Disease (MRD) Testing Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Mission Bio Recent Developments and Future Plans
2.6 LabCorp
2.6.1 LabCorp Details
2.6.2 LabCorp Major Business
2.6.3 LabCorp Minimal Residual Disease (MRD) Testing Product and Solutions
2.6.4 LabCorp Minimal Residual Disease (MRD) Testing Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 LabCorp Recent Developments and Future Plans
2.7 Guardant Health
2.7.1 Guardant Health Details
2.7.2 Guardant Health Major Business
2.7.3 Guardant Health Minimal Residual Disease (MRD) Testing Product and Solutions
2.7.4 Guardant Health Minimal Residual Disease (MRD) Testing Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Guardant Health Recent Developments and Future Plans
2.8 NeoGenomics Laboratories
2.8.1 NeoGenomics Laboratories Details
2.8.2 NeoGenomics Laboratories Major Business
2.8.3 NeoGenomics Laboratories Minimal Residual Disease (MRD) Testing Product and Solutions
2.8.4 NeoGenomics Laboratories Minimal Residual Disease (MRD) Testing Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 NeoGenomics Laboratories Recent Developments and Future Plans
2.9 ARUP Laboratories
2.9.1 ARUP Laboratories Details
2.9.2 ARUP Laboratories Major Business
2.9.3 ARUP Laboratories Minimal Residual Disease (MRD) Testing Product and Solutions
2.9.4 ARUP Laboratories Minimal Residual Disease (MRD) Testing Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 ARUP Laboratories Recent Developments and Future Plans
2.10 NeoGenomics , Inc
2.10.1 NeoGenomics , Inc Details
2.10.2 NeoGenomics , Inc Major Business
2.10.3 NeoGenomics , Inc Minimal Residual Disease (MRD) Testing Product and Solutions
2.10.4 NeoGenomics , Inc Minimal Residual Disease (MRD) Testing Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 NeoGenomics , Inc Recent Developments and Future Plans
2.11 Opko Health
2.11.1 Opko Health Details
2.11.2 Opko Health Major Business
2.11.3 Opko Health Minimal Residual Disease (MRD) Testing Product and Solutions
2.11.4 Opko Health Minimal Residual Disease (MRD) Testing Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Opko Health Recent Developments and Future Plans
2.12 Bio-Rad Laboratories
2.12.1 Bio-Rad Laboratories Details
2.12.2 Bio-Rad Laboratories Major Business
2.12.3 Bio-Rad Laboratories Minimal Residual Disease (MRD) Testing Product and Solutions
2.12.4 Bio-Rad Laboratories Minimal Residual Disease (MRD) Testing Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Bio-Rad Laboratories Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Minimal Residual Disease (MRD) Testing Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Minimal Residual Disease (MRD) Testing by Company Revenue
3.2.2 Top 3 Minimal Residual Disease (MRD) Testing Players Market Share in 2022
3.2.3 Top 6 Minimal Residual Disease (MRD) Testing Players Market Share in 2022
3.3 Minimal Residual Disease (MRD) Testing Market: Overall Company Footprint Analysis
3.3.1 Minimal Residual Disease (MRD) Testing Market: Region Footprint
3.3.2 Minimal Residual Disease (MRD) Testing Market: Company Product Type Footprint
3.3.3 Minimal Residual Disease (MRD) Testing Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Minimal Residual Disease (MRD) Testing Consumption Value and Market Share by Type (2018-2023)
4.2 Global Minimal Residual Disease (MRD) Testing Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
5.1 Global Minimal Residual Disease (MRD) Testing Consumption Value Market Share by Application (2018-2023)
5.2 Global Minimal Residual Disease (MRD) Testing Market Forecast by Application (2024-2029)
6 North America
6.1 North America Minimal Residual Disease (MRD) Testing Consumption Value by Type (2018-2029)
6.2 North America Minimal Residual Disease (MRD) Testing Consumption Value by Application (2018-2029)
6.3 North America Minimal Residual Disease (MRD) Testing Market Size by Country
6.3.1 North America Minimal Residual Disease (MRD) Testing Consumption Value by Country (2018-2029)
6.3.2 United States Minimal Residual Disease (MRD) Testing Market Size and Forecast (2018-2029)
6.3.3 Canada Minimal Residual Disease (MRD) Testing Market Size and Forecast (2018-2029)
6.3.4 Mexico Minimal Residual Disease (MRD) Testing Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe Minimal Residual Disease (MRD) Testing Consumption Value by Type (2018-2029)
7.2 Europe Minimal Residual Disease (MRD) Testing Consumption Value by Application (2018-2029)
7.3 Europe Minimal Residual Disease (MRD) Testing Market Size by Country
7.3.1 Europe Minimal Residual Disease (MRD) Testing Consumption Value by Country (2018-2029)
7.3.2 Germany Minimal Residual Disease (MRD) Testing Market Size and Forecast (2018-2029)
7.3.3 France Minimal Residual Disease (MRD) Testing Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Minimal Residual Disease (MRD) Testing Market Size and Forecast (2018-2029)
7.3.5 Russia Minimal Residual Disease (MRD) Testing Market Size and Forecast (2018-2029)
7.3.6 Italy Minimal Residual Disease (MRD) Testing Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific Minimal Residual Disease (MRD) Testing Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Minimal Residual Disease (MRD) Testing Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Minimal Residual Disease (MRD) Testing Market Size by Region
8.3.1 Asia-Pacific Minimal Residual Disease (MRD) Testing Consumption Value by Region (2018-2029)
8.3.2 China Minimal Residual Disease (MRD) Testing Market Size and Forecast (2018-2029)
8.3.3 Japan Minimal Residual Disease (MRD) Testing Market Size and Forecast (2018-2029)
8.3.4 South Korea Minimal Residual Disease (MRD) Testing Market Size and Forecast (2018-2029)
8.3.5 India Minimal Residual Disease (MRD) Testing Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Minimal Residual Disease (MRD) Testing Market Size and Forecast (2018-2029)
8.3.7 Australia Minimal Residual Disease (MRD) Testing Market Size and Forecast (2018-2029)
9 South America
9.1 South America Minimal Residual Disease (MRD) Testing Consumption Value by Type (2018-2029)
9.2 South America Minimal Residual Disease (MRD) Testing Consumption Value by Application (2018-2029)
9.3 South America Minimal Residual Disease (MRD) Testing Market Size by Country
9.3.1 South America Minimal Residual Disease (MRD) Testing Consumption Value by Country (2018-2029)
9.3.2 Brazil Minimal Residual Disease (MRD) Testing Market Size and Forecast (2018-2029)
9.3.3 Argentina Minimal Residual Disease (MRD) Testing Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa Minimal Residual Disease (MRD) Testing Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Minimal Residual Disease (MRD) Testing Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Minimal Residual Disease (MRD) Testing Market Size by Country
10.3.1 Middle East & Africa Minimal Residual Disease (MRD) Testing Consumption Value by Country (2018-2029)
10.3.2 Turkey Minimal Residual Disease (MRD) Testing Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Minimal Residual Disease (MRD) Testing Market Size and Forecast (2018-2029)
10.3.4 UAE Minimal Residual Disease (MRD) Testing Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 Minimal Residual Disease (MRD) Testing Market Drivers
11.2 Minimal Residual Disease (MRD) Testing Market Restraints
11.3 Minimal Residual Disease (MRD) Testing Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 Minimal Residual Disease (MRD) Testing Industry Chain
12.2 Minimal Residual Disease (MRD) Testing Upstream Analysis
12.3 Minimal Residual Disease (MRD) Testing Midstream Analysis
12.4 Minimal Residual Disease (MRD) Testing Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

Published By : GlobalInfoResearch

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock